| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value. | Clin Cancer Res | 2012 | 3.07 |
| 2 | Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31. | J Natl Cancer Inst | 2013 | 2.28 |